The Liver Research Center, Rhode Island Hospital, Providence, RI, USA.
J Virol. 2011 Oct;85(19):10167-77. doi: 10.1128/JVI.00819-11. Epub 2011 Jul 20.
Infection by hepatitis B virus (HBV) genotype C is associated with a prolonged viremic phase, delayed hepatitis B e antigen (HBeAg) seroconversion, and an increased incidence of liver cirrhosis and hepatocellular carcinoma compared with genotype B infection. Genotype C is also associated with the more frequent emergence of core promoter mutations, which increase genome replication and are independently associated with poor clinical outcomes. We amplified full-length HBV genomes from serum samples from Chinese and U. S. patients with chronic HBV infection and transfected circularized genome pools or dimeric constructs of individual clones into Huh7 cells. The two genotypes could be differentiated by Western blot analysis due to the reactivities of M and L proteins toward a monoclonal pre-S2 antibody and slightly different S-protein mobilities. Great variability in replication capacity was observed for both genotypes. The A1762T/G1764A core promoter mutations were prevalent in genotype C isolates and correlated with increased replication capacity, while the A1752G/T mutation frequently found in genotype B isolates correlated with a low replication capacity. Importantly, most genotype C isolates with wild-type core promoter sequence replicated less efficiently than the corresponding genotype B isolates due to less efficient transcription of the 3.5-kb RNA. However, genotype C isolates often displayed more efficient virion secretion. We propose that the low intracellular levels of viral DNA and core protein of wild-type genotype C delay immune clearance and trigger the subsequent emergence of A1762T/G1764A core promoter mutations to upregulate replication; efficient virion secretion compensates for the low replication capacity to ensure the establishment of persistent infection by genotype C.
乙型肝炎病毒(HBV)基因型 C 的感染与病毒血症持续时间延长、乙型肝炎 e 抗原(HBeAg)血清学转换延迟以及肝硬化和肝细胞癌的发生率增加有关,与基因型 B 感染相比。基因型 C 还与核心启动子突变的更频繁出现有关,这些突变增加了基因组复制,并且与不良临床结局独立相关。我们从慢性 HBV 感染的中国和美国患者的血清样本中扩增了全长 HBV 基因组,并将圆形化基因组池或单个克隆的二聚体构建体转染到 Huh7 细胞中。两种基因型可以通过 Western blot 分析区分,因为 M 和 L 蛋白对单克隆 pre-S2 抗体的反应性以及 S 蛋白的迁移率略有不同。两种基因型的复制能力都存在很大的变异性。A1762T/G1764A 核心启动子突变在基因型 C 分离株中很常见,与复制能力增加相关,而在基因型 B 分离株中经常发现的 A1752G/T 突变与低复制能力相关。重要的是,由于 3.5kb RNA 的转录效率较低,大多数具有野生型核心启动子序列的基因型 C 分离株的复制效率低于相应的基因型 B 分离株。然而,基因型 C 分离株通常表现出更高的病毒粒子分泌效率。我们提出,野生型基因型 C 的低细胞内病毒 DNA 和核心蛋白水平会延迟免疫清除,并引发随后出现的 A1762T/G1764A 核心启动子突变以上调复制;高效的病毒粒子分泌补偿了低复制能力,以确保基因型 C 的持续感染的建立。